Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

• Explainable machine learning identifies features and thresholds predictive of immunotherapy response

  2026 Scientific Reports article Medicine Cancer Immunotherapy and Biomarkers Open access

  1

  citations
• Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells

  2024 Cancer Cell article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 3 patents

  112

  citations
• Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells

  2024 Cell Reports Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access

  55

  citations
• Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma

  2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers

  23

  citations
• Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

  2023 Nature Medicine article Medicine Salivary Gland Tumors Diagnosis and Treatment Open access

  65

  citations
• Lack of detectable neoantigen depletion in treatment-naïve cancers

  2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer

  2023 Science Translational Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access

  94

  citations
• Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review

  2021 Cancers review Medicine Cancer Immunotherapy and Biomarkers Open access

  27

  citations
• PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?

  2021 Urologic Oncology Seminars and Original Investigations article Medicine Cancer Immunotherapy and Biomarkers

  14

  citations
• Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

  2020 British Journal of Cancer erratum Medicine Cancer Immunotherapy and Biomarkers Open access

  15

  citations
• A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

  2020 British Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  40

  citations
• Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors

  2020 Cancer Immunology Research article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  15

  citations
• Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response

  2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  109

  citations

13 results